[go: up one dir, main page]

DK0691986T3 - Hidtil ukendte fremgangsmåder og mellemproduktforbindelser til fremstillingen af blodpladeglycoprotein IIb/IIIa-inhibitorer - Google Patents

Hidtil ukendte fremgangsmåder og mellemproduktforbindelser til fremstillingen af blodpladeglycoprotein IIb/IIIa-inhibitorer

Info

Publication number
DK0691986T3
DK0691986T3 DK94911702T DK94911702T DK0691986T3 DK 0691986 T3 DK0691986 T3 DK 0691986T3 DK 94911702 T DK94911702 T DK 94911702T DK 94911702 T DK94911702 T DK 94911702T DK 0691986 T3 DK0691986 T3 DK 0691986T3
Authority
DK
Denmark
Prior art keywords
preparation
intermediate compounds
glycoprotein iib
platelet glycoprotein
novel methods
Prior art date
Application number
DK94911702T
Other languages
English (en)
Inventor
William Frank Degrado
Lin-Hua Zhang
Philip Ma
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Application granted granted Critical
Publication of DK0691986T3 publication Critical patent/DK0691986T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/75Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK94911702T 1993-03-29 1994-03-28 Hidtil ukendte fremgangsmåder og mellemproduktforbindelser til fremstillingen af blodpladeglycoprotein IIb/IIIa-inhibitorer DK0691986T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3843493A 1993-03-29 1993-03-29
PCT/US1994/003221 WO1994022909A1 (en) 1993-03-29 1994-03-28 NOVEL PROCESSES AND INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF PLATELET CLYCOPROTEIN IIb/IIIa INHIBITORS

Publications (1)

Publication Number Publication Date
DK0691986T3 true DK0691986T3 (da) 1999-08-16

Family

ID=21899933

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94911702T DK0691986T3 (da) 1993-03-29 1994-03-28 Hidtil ukendte fremgangsmåder og mellemproduktforbindelser til fremstillingen af blodpladeglycoprotein IIb/IIIa-inhibitorer

Country Status (12)

Country Link
US (1) US5817749A (da)
EP (1) EP0691986B1 (da)
JP (1) JPH08509708A (da)
AT (1) ATE174036T1 (da)
AU (1) AU682857B2 (da)
CA (1) CA2159072A1 (da)
DE (1) DE69415001T2 (da)
DK (1) DK0691986T3 (da)
ES (1) ES2126748T3 (da)
GR (1) GR3029453T3 (da)
NZ (1) NZ263455A (da)
WO (1) WO1994022909A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA978758B (en) * 1996-10-02 1999-03-30 Du Pont Merck Pharma Technetium-99m-labeled chelator incorporated cyclic peptides that bind to the GPIIb/IIIa receptor as imaging agents

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3505555A1 (de) * 1985-02-18 1986-09-11 Behringwerke Ag, 3550 Marburg Neue oligopeptidylargininolderivate und deren homologe, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel
FR2636066B1 (fr) * 1988-09-02 1991-10-25 Centre Nat Rech Scient Derives de cyclopeptides, utilisables comme inhibiteurs selectifs vis-a-vis de proteases a serine active
JP2945680B2 (ja) * 1988-09-09 1999-09-06 旭硝子株式会社 ペプチド誘導体およびその用途
DD289543A5 (de) * 1989-05-12 1991-05-02 Univ Halle Wittenberg Neue pharmakologisch-aktive cyclopeptide und verfahren zu ihrer herstellung
US5384309A (en) * 1989-07-17 1995-01-24 Genentech, Inc. Cyclized peptides and their use as platelet aggregation inhibitors
NZ235564A (en) * 1989-10-13 1993-10-26 Merck & Co Inc Fibrinogen receptor antagonist and pharmaceutical compositions
AU6470590A (en) * 1989-10-23 1991-04-26 Smithkline Beecham Corporation Cyclic anti-aggregatory peptides
CA2036973A1 (en) * 1990-02-27 1991-08-28 Mark G. Bock Cyclic hexapeptide oxytocin antagonists
US5192746A (en) * 1990-07-09 1993-03-09 Tanabe Seiyaku Co., Ltd. Cyclic cell adhesion modulation compounds
JPH05508859A (ja) * 1990-07-24 1993-12-09 イーストマン コダック カンパニー ペプチド合成方法
EP0555328A1 (en) * 1990-11-02 1993-08-18 Genentech, Inc. Platelet aggregation inhibitors
IL103252A (en) * 1991-09-30 1997-03-18 Du Pont Merck Pharma CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CA2153228A1 (en) * 1993-01-08 1994-07-21 Shiu-Lan Ng Chiang Peptide inhibitors of cell adhesion
EP0694041A1 (en) * 1993-03-29 1996-01-31 The Du Pont Merck Pharmaceutical Company A PROCESS AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF PLATELET GLYCOPROTEIN IIb/IIIa INHIBITORS CONTAINING N-ALPHA-METHYLARGININE
AU6415894A (en) * 1993-03-29 1994-10-24 Du Pont Merck Pharmaceutical Company, The Cyclic compounds useful as inhibitors of platelet glycoprotein iib/iiia

Also Published As

Publication number Publication date
AU682857B2 (en) 1997-10-23
ES2126748T3 (es) 1999-04-01
US5817749A (en) 1998-10-06
JPH08509708A (ja) 1996-10-15
EP0691986B1 (en) 1998-12-02
WO1994022909A1 (en) 1994-10-13
NZ263455A (en) 1997-10-24
GR3029453T3 (en) 1999-05-28
AU6415794A (en) 1994-10-24
DE69415001T2 (de) 1999-05-06
ATE174036T1 (de) 1998-12-15
DE69415001D1 (de) 1999-01-14
EP0691986A1 (en) 1996-01-17
CA2159072A1 (en) 1994-10-13

Similar Documents

Publication Publication Date Title
BR9509665A (pt) Composto composições e métodos
DE69528829D1 (de) Präparate zur hemmung der durch osteoklasten vermittelten knochenresorption
DK0693073T3 (da) Bicykliske ansamyciner og deres anvendelse som antitumormidler
DK0513543T3 (da) Amidinophenylalaninderivater, fremgangsmåde til deres fremstilling, deres anvendelse og antikoagulationsmidler med indehold deraf
BR9408246A (pt) Composto derivado de 3-azabicicloalcano N-substituído
DK0790988T3 (da) Anvendelse af dioxomorpholiner til bekæmpelse af endoparasitter, nye dioxomorpholiner og fremgangsmåder til deres fremstilling
DE69401658D1 (de) Verwendung von deoxygalactonojirimycin derivaten zu hemmung der glycolipid synthese
DK0532515T3 (da) Fremstilling af substituerede piperidiner
DK0619806T3 (da) Fremstilling af substituerede piperidiner
DK0730581T3 (da) 3-acylaminobezazepiner
NZ228065A (en) 1,2,4-triazinediones and parasiticidal compositions; processes for preparation
DK0552765T3 (da) benzimidazoler, farmaceutiske præparater indeholdende disse og fremgangsmåde til deres fremstilling
DK0691986T3 (da) Hidtil ukendte fremgangsmåder og mellemproduktforbindelser til fremstillingen af blodpladeglycoprotein IIb/IIIa-inhibitorer
BR0010488A (pt) Tienocicloalqu(en)ilamino-1,3,5-triazinas substituìdas
ATE282608T1 (de) Chinoxalindionen
NO955278D0 (no) Substituerte aryltiolalkyltiopyridiner
MX9305467A (es) Compuestos intermedios, quirales, de quinolona y procedimiento para su preparacion.
NO305556B1 (no) Tiokarbamoylforbindelser og anvendelse derav samt middel for beskyttelse av tekniske materialer
DK0680467T3 (da) Fremgangsmåde til fremstilling af C-substituerede diethylentriaminer
DK0427160T3 (da) Benzylselenobenzamid af aminopyridiner og picolylaminer
DK0544171T3 (da) Anvendelse af 5,6-dihydro-dibenz(b,e)azepin-6,11-dion-11-oximer til fremstilling af antiretrovirale midler
DK0433978T3 (da) Fremgangsmåde til fremstilling af nojirimycin og beslægtede forbindelser